$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$1.57B
Market Cap
-
P/E Ratio
-2.77
EPS
$19.16
52 Week High
$5.15
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Immunome, Inc. is a cutting-edge biopharmaceutical company based in Exton, Pennsylvania, focused on developing innovative antibody therapies for oncology and infectious diseases. Leveraging its proprietary platform for therapeutic antibody identification, Immunome is advancing a promising pipeline of candidates that address significant unmet medical needs. The company’s approach harnesses the power of the immune system, positioning Immunome at the forefront of transforming treatment paradigms in some of the most challenging disease areas, thus representing an attractive opportunity for institutional investors seeking exposure to the biotechnology sector.
LPTX
VRAX
NVDA
VHAI
IPG
ASST
F
ADAP
PFE
NIO
CLSK
ITUB
GOOGL
GRAB
PLTD
ASBP
MTSR
PCG
HOOD
BA
IREN
STLA
VALE
LUMN
AMCR
SMCI
PMAX
MRVL
RR
AKTX
BITF
PLUG
KDLY
CSCO
SAND
BMY
INTC
CDE
AUR
SHOT
ZAPP
LYFT
IONQ
CAPR
ARTL
NFLX
HIMS
ALIT
CPNG
AEO
SNDK
USB
SCHW
CAG
BABA
TXN
AMAT
NEM
TEVA
APH
LPTX
VRAX
NVDA
VHAI
IPG
ASST
F
ADAP
PFE
NIO
CLSK
ITUB
GOOGL
GRAB
PLTD
ASBP
MTSR
PCG
HOOD
BA
IREN
STLA
VALE
LUMN
AMCR
SMCI
PMAX
MRVL
RR
AKTX
BITF
PLUG
KDLY
CSCO
SAND
BMY
INTC
CDE
AUR
SHOT
ZAPP
LYFT
IONQ
CAPR
ARTL
NFLX
HIMS
ALIT
CPNG
AEO
SNDK
USB
SCHW
CAG
BABA
TXN
AMAT
NEM
TEVA
APH